Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of a model for early prediction of severe/critical COVID-19 in elderly patients.

PeerJ·2026
Same author

Association Between Time-Averaged Serum Uric Acid and Renal Outcomes in Patients with Type 2 Diabetes Mellitus with Chronic Kidney Disease: A Multicenter Retrospective Cohort Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2026
Same author

Clinical, functional, and immunological profiles across frailty subgroups in maintenance hemodialysis patient.

Frontiers in endocrinology·2026
Same author

ER-Golgi dysfunction and vesicular transport alterations in rheumatoid arthritis immune cells.

Frontiers in immunology·2026
Same author

PRMT1 and its Substrates: Novel functions in kidney and metabolic diseases.

Diabetes research and clinical practice·2026
Same author

Chronic kidney disease burden from 1990 to 2023 in China: national and provincial insights from the Global Burden of Diseases study 2023.

The Lancet regional health. Western Pacific·2026

Related Experiment Video

Updated: Jul 14, 2026

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
12:00

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles

Published on: January 22, 2015

Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.

Zonghua Liu1, Yanpeng Jiao, Fanna Liu

  • 1Department of Materials Science and Engineering, Jinan University, Guangzhou, China, 510632.

Journal of Biomedical Materials Research. Part A
|June 15, 2007
PubMed
Summary

Novel nanoparticles were created using heparin and chitosan polyelectrolyte complexation. Optimizing conditions like pH and concentrations maximized nanoparticle yield and bovine serum albumin (BSA) protein entrapment.

More Related Videos

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles
05:55

Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles

Published on: September 18, 2018

Related Experiment Videos

Last Updated: Jul 14, 2026

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
12:00

Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles

Published on: January 22, 2015

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles
05:55

Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles

Published on: September 18, 2018

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Drug Delivery

Background:

  • Heparin and chitosan are biocompatible polymers with potential in nanoparticle formulation.
  • Polyelectrolyte complexation offers a mild and efficient method for nanoparticle synthesis.
  • Protein encapsulation within nanoparticles is crucial for targeted drug delivery applications.

Purpose of the Study:

  • To develop novel nanoparticles via polyelectrolyte complexation of heparin and chitosan.
  • To characterize the physical properties of the synthesized nanoparticles.
  • To investigate the factors influencing nanoparticle formation and protein entrapment efficiency.

Main Methods:

  • Nanoparticle synthesis using polyelectrolyte complexation between heparin and chitosan.
  • Characterization of nanoparticle size, polydispersity, zeta potential, and morphology.
  • Entrapment studies using bovine serum albumin (BSA) as a model protein.
  • Systematic investigation of parameters: pH, chitosan molecular weight (MW), polymer concentrations, and BSA concentration.

Main Results:

  • Nanoparticle size and yield were significantly influenced by preparation parameters.
  • Nanoparticle yield was directly correlated with BSA entrapment capacity.
  • Optimal conditions included a high pH for chitosan solution, moderate chitosan MW, and specific concentration ratios of heparin and chitosan.

Conclusions:

  • Heparin-chitosan nanoparticles can be effectively prepared under mild conditions.
  • Parameter optimization is key to maximizing nanoparticle yield and protein encapsulation.
  • These findings support the potential of heparin-chitosan nanoparticles for protein delivery systems.